News

US FDA approves Verastem's ovarian cancer therapy
The U.S. Food and Drug Administration has approved Verastem's combination therapy for patients with a rare type of ovarian ...
Verastem Gets FDA Approval of AVMAPKI/FAKZYNJA Combination for Adult Patients With KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
US FDA approves Verastem's cancer therapy
The U.S. Food and Drug Administration has approved Verastem's combination therapy for patients with a type of ovarian cancer ...